An automated system for delivery of an unstable transcription factor to hematopoietic stem cell cultures
- 12 February 2009
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 103 (2) , 402-412
Abstract
An automated delivery system for cell culture applications would permit studying more complex culture strategies and simplify measures taken to expose cells to unstable molecules. We are interested in understanding how intracellular TAT‐HOXB4 protein concentration affects hematopoietic stem cell (HSC) fate; however, current manual dosing strategies of this unstable protein are labor intensive and produce wide concentration ranges which may not promote optimal growth. In this study we describe a programmable automated delivery system that was designed to integrate into a clinically relevant, single‐use, closed‐system bioprocess and facilitate transcription factor delivery studies. The development of a reporter cell assay allowed for kinetic studies to determine the intracellular (1.4 ± 0.2 h) and extracellular (3.7 ± 1.8 h and 78 ± 27 h at 37°C and 4°C, respectively) half‐lives of TAT‐HOXB4 activity. These kinetic parameters were incorporated into a mathematical model, which was used to predict the dynamic intracellular concentration of TAT‐HOXB4 and optimize the delivery of the protein. The automated system was validated for primary cell culture using human peripheral blood patient samples. Significant expansion of human primitive progenitor cells was obtained upon addition of TAT‐HOXB4 without user intervention. The delivery system is thus capable of being used as a clinically relevant tool for the exploration and optimization of temporally sensitive stem cell culture systems. Biotechnol. Bioeng. 2009;103: 402–412.Keywords
This publication has 23 references indexed in Scilit:
- The taming of the cell penetrating domain of the HIV Tat: Myths and realitiesJournal of Controlled Release, 2007
- Clinically Relevant Expansion of Hematopoietic Stem Cells with Conserved Function in a Single-Use, Closed-System BioprocessTransplantation and Cellular Therapy, 2006
- Cargo‐dependent mode of uptake and bioavailability of TAT‐containing proteins and peptides in living cellsThe FASEB Journal, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particlesJournal of Microencapsulation, 2006
- Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansionExperimental Hematology, 2005
- TAT‐mediated endocytotic delivery of the loop deletion Bcl‐2 protein protects neurons against cell deathJournal of Neurochemistry, 2005
- Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentrationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Uptake of analogs of penetratin, Tat(48–60) and oligoarginine in live cellsBiochemical and Biophysical Research Communications, 2003
- Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture systemBone Marrow Transplantation, 1998